CorMedix Inc. (CRMD) Fundamentals

Cormedix Inc is a biopharmaceutical company that focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It has been in-licensed to develop and commercialize Neutrolin, which is a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings such as hemodialysis, total parenteral nutrition, and oncology. The Neutrolin product is designed to target unmet medical needs.
SHARE INFORMATION
Market Cap$ 140,452,500
Shares Outstanding39,123,259
Float38,741,593
Percent Float99.02%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 190,937
Latest Fiscal EPS$ -0.75
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions182
Institutional Holdings Date2022-05-31
Institutional Bought Previous 3 Months658,789
Institutional Holdings Percent60.6%
Institutional Sold Previous 3 Months777,521
Insider Holdings Date2022-05-31
Insider Bought Previous 3 Months727,469
Insider Holdings Percent10.3
Insider Sold Previous 3 Months-
Insider Shares Owned4,035,665
TRADING INFO
52 Week High$ 7.70
52 Week Low$ 2.65
52 Week High Change$ -49.79
21 Day Moving Average$ 3.1186
21 Day Extended Moving Average$ 3.2586
50 Day Moving Average$ 3.3734
50 Day Extended Moving Average$ 3.4966
200 Day Moving Average$ 4.4415
200 Day Extended Moving Average$ 4.5619
10 Day Average Volume785,901
20 Day Average Volume596,849
30 Day Average Volume509,712
50 Day Average Volume464,404
Alpha0.023023
Beta2.4078
Standard Deviation0.320716
R20.126398
7 Day Price Change$ 0.39
7 Day Percent Change12.19%
21 Day Price Change$ 0.40
21 Day Percent Change12.54%
30 Day Price Change$ 0.49
30 Day Percent Change15.81%
Month to Date Price Change$ 0.35
Month to Date Percent Change10.8%
Quarter to Date Price Change$ -1.89
Quarter to Date Percent Change-34.49%
180 Day Price Change$ -0.88
180 Day Percent Change-19.69%
200 Day Price Change$ -1.39
200 Day Percent Change-27.91%
Year to Date Price Change$ -0.96
Year to Date Percent Change-21.1%

CorMedix Inc. (CRMD) Key Ratios

PROFITABILITY
EBIT Margin-26,526.4%
EBITDA Margin-26,462.8%
Pre-Tax Profit Margin-9,807.4%
Profit Margin Count0.0%
Gross Margin19.2%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 110,312
Revenue Per Share$ 0.0028
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.30
Total Debt To Equity0.00
Int Coverage-1,809.50
Current Ratio14.60
Leverage Ratio1.10
Quick Ratio14.40
Long Term Debt To Capital0.01
VALUATION MEASURES
PE Ratio-4.90
Enterprise Value$ 78,486,100
Price to Sales1,273.2296
Price to Free Cash-6.20
PE High Last 5 Years-3.90
Price To Book2.30
Price To Cash Flow0.00
PE Low Last 5 Years-5.70
Price to Tangible Book2.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover36.20
Invoice Turnover2.10
Assets Turnover0.00
Return Assets-38.79
Return on Equity-41.31
Return on Capital-39.46

CorMedix Inc. (CRMD) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorFriedman LLP
CEOMatthew T. David / Matthew David
Emplyoees30
Last AuditUQ
CIK0001410098
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address300 Connell Drive
Suite 4200
Berkeley Heights, NJ 7922
Websitehttps://www.cormedix.com
Facsimile+1 908 375-8272
Telephone+1 908 517-9500
Emaildaniel@lifesciadvisors.com


Your Recent History
AMEX
CRMD
CorMedix
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.